Published in PPAR Res on January 01, 2007
PPARs and the cardiovascular system. Antioxid Redox Signal (2009) 1.28
Lactobacillus rhamnosus accelerates zebrafish backbone calcification and gonadal differentiation through effects on the GnRH and IGF systems. PLoS One (2012) 0.84
Nuclear receptors and nonalcoholic fatty liver disease. Biochim Biophys Acta (2016) 0.81
Muscle development and obesity: Is there a relationship? Organogenesis (2008) 0.80
The Functions of PPARs in Aging and Longevity. PPAR Res (2007) 0.78
Muscle-Specific PPARbeta/delta Agonism May Provide Synergistic Benefits with Life Style Modifications. PPAR Res (2007) 0.75
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature (2002) 14.37
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem (1995) 13.34
15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell (1995) 11.72
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev (1994) 10.44
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature (1998) 8.33
Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology (1996) 7.92
Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell (2003) 6.53
Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol (2004) 5.66
The PPARalpha-leukotriene B4 pathway to inflammation control. Nature (1996) 5.14
Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature (2003) 4.60
Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest (1985) 4.38
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell (1999) 4.32
A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A (2001) 4.22
Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A (2003) 4.03
Exercise, glucose transport, and insulin sensitivity. Annu Rev Med (1998) 4.00
PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol (1995) 3.14
Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J (2003) 2.80
Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J (2005) 2.48
Muscle fiber type is associated with obesity and weight loss. Am J Physiol Endocrinol Metab (2002) 2.38
Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev (1999) 2.37
Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J Biol Chem (2002) 2.25
Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. J Appl Physiol (1985) (2001) 2.24
The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol (2003) 2.17
Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity. Bioorg Med Chem Lett (2003) 1.90
Regulation of adipocytokines and insulin resistance. Diabetologia (2003) 1.90
Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J Biol Chem (1996) 1.88
Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem (1995) 1.88
The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J Mol Endocrinol (1993) 1.69
Lipotoxic diseases of nonadipose tissues in obesity. Int J Obes Relat Metab Disord (2000) 1.37
Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator. Proc Natl Acad Sci U S A (2002) 1.36
Training induced changes in the subgroups of human type II skeletal muscle fibres. Acta Physiol Scand (1977) 1.24
Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions. Curr Opin Biotechnol (1999) 1.20
Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes. J Mol Endocrinol (2004) 1.20
Molecular mechanism of insulin resistance and obesity. Exp Biol Med (Maywood) (2003) 1.19
Nutritional regulation and role of peroxisome proliferator-activated receptor delta in fatty acid catabolism in skeletal muscle. Biochim Biophys Acta (2003) 1.15
Low-intensity exercise increases skeletal muscle protein expression of PPARdelta and UCP3 in type 2 diabetic patients. Diabetes Metab Res Rev (2006) 1.11
Muscle adaptation to extreme endurance training in man. Acta Physiol Scand (1977) 1.02
Induction of aP2 gene expression by nonmetabolized long-chain fatty acids. Proc Natl Acad Sci U S A (1992) 0.95
Muscle plasticity and metabolism: effects of exercise and chronic diseases. Mol Aspects Med (1999) 0.86
Roles of skeletal muscle and peroxisome proliferator-activated receptors in the development and treatment of obesity. Endocr Rev (2006) 0.79
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev (2006) 3.48
Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J (2003) 2.80
Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes. Biochim Biophys Acta (2004) 1.21
CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress. J Biol Chem (2008) 1.16
CD36 in myocytes channels fatty acids to a lipase-accessible triglyceride pool that is related to cell lipid and insulin responsiveness. Diabetes (2004) 1.15
Nutritional regulation and role of peroxisome proliferator-activated receptor delta in fatty acid catabolism in skeletal muscle. Biochim Biophys Acta (2003) 1.15
Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis. Cardiovasc Res (2005) 1.09
Pharmacological activation of PPARbeta promotes rapid and calcineurin-dependent fiber remodeling and angiogenesis in mouse skeletal muscle. Am J Physiol Endocrinol Metab (2008) 1.06
Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice. Diabetes (2012) 1.06
New factors in the regulation of adipose differentiation and metabolism. Curr Opin Lipidol (2002) 0.89
Roles of peroxisome proliferator-activated receptors delta and gamma in myoblast transdifferentiation. Exp Cell Res (2003) 0.88
Modulation of peroxisome proliferator-activated receptor delta activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation. Mol Pharmacol (2005) 0.82
PPARdelta mediates IL15 metabolic actions in myotubes: effects of hyperthermia. Int J Mol Med (2009) 0.81
Roles of peroxisome proliferator-activated receptor delta in skeletal muscle function and adaptation. Curr Opin Clin Nutr Metab Care (2004) 0.80
Roles of skeletal muscle and peroxisome proliferator-activated receptors in the development and treatment of obesity. Endocr Rev (2006) 0.79